Online Only Articles

A confirmation of chronic graft-versus-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantation

Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA
Division of Hematology, Saitama Medical Center, Jichi Medicial University, Saitama, Japan
Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA
Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA
Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA
Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA
The Emmes Corporation, Rockville, MD, USA
Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA
Division of Pediatrics BMT, Minneapolis, MN, USA
Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA
Center for International Blood and Marrow Transplant Research, Minneapolis Campus, Minneapolis, MN, USA
Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA
Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA
Vol. 104 No. 7 (2019): July, 2019 https://doi.org/10.3324/haematol.2018.199646